Advanced search
Publication Cover
Expert Review of Hematology Volume 11, 2018 - Issue 2
Submit an article Journal homepage
351
Views
12
CrossRef citations to date
0
Altmetric
Review

A contemporary look at FVIII inhibitor development: still a great influence on the evolution of hemophilia therapies

Elena SantagostinoAngelo Bianchi Bonomi Hemophilia and Thrombosis Center, University of Milan, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, ItalyCorrespondence[email protected]
View further author information
,
Guy YoungHemostasis and Thrombosis Center, Children’s Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USAView further author information
,
Manuel CarcaoDivision of Hematology/Oncology; Department of Pediatrics and Child Health Evaluative Sciences, Research Institute Hospital for Sick Children, Toronto, ON, CanadaView further author information
,
Pier Mannuccio MannucciScientific Direction, IRCCS Ca’ Granda Ospedale Maggiore Policlinico and University of Milan, Milan, ItalyView further author information
,
Susan HalimehGerinnungszentrum Rhein-Ruhr (GZRR), Duisburg, GermanyView further author information
&
Steve AustinSt. George’s Healthcare NHS Trust Haemophilia Centre, London, UKView further author information
Pages 87-97 | Received 29 Nov 2017, Accepted 18 Dec 2017, Published online: 04 Jan 2018

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Katharine Batt, Bob G. Schultz, Jorge Caicedo, Christopher S. Hollenbeak, Neha Agrawal, Sagnik Chatterjee & Michael Bullano. (2022) A real-world study comparing pre-post billed annualized bleed rates and total cost of care among non-inhibitor patients with hemophilia A switching from FVIII prophylaxis to emicizumab. Current Medical Research and Opinion 38:10, pages 1685-1693.
Read now

Articles from other publishers (11)

Debora Bertaggia Calderara, Rita Marchi Cappelletti, Ana Patricia Batista Mesquita Sauvage, Stéphane Durual, Francisco J. Gomez, Maxime G. Zermatten, Alessandro Aliotta, Alessandro Casini & Lorenzo Alberio. (2023) Pharmacodynamics Monitoring of Emicizumab in Patients with Hemophilia A. Thrombosis and Haemostasis.
Crossref
Víctor Jiménez-Yuste. 2022. Advances in Hemophilia Treatment. Advances in Hemophilia Treatment 45 51 .
Thembaninkosi G. Gaule & Ramzi A. Ajjan. (2021) Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges. International Journal of Molecular Sciences 22:13, pages 6916.
Crossref
Bendix Samarta Witarto, Visuddho Visuddho, Andro Pramana Witarto, Henry Sutanto, Bayu Satria Wiratama & Citrawati Dyah Kencono Wungu. (2022) Efficacy, safety, and immunogenicity of rurioctocog alfa pegol for prophylactic treatment in previously treated patients with severe hemophilia A: a systematic review and meta-analysis of clinical trials. F1000Research 10, pages 1049.
Crossref
Bendix Samarta Witarto, Visuddho Visuddho, Andro Pramana Witarto, Henry Sutanto, Bayu Satria Wiratama & Citrawati Dyah Kencono Wungu. (2021) Efficacy, safety, and immunogenicity of rurioctocog alfa pegol for prophylactic treatment in previously treated patients with severe hemophilia A: a systematic review and meta-analysis of clinical trials. F1000Research 10, pages 1049.
Crossref
Georg Gelbenegger, Christian Schoergenhofer, Paul Knoebl & Bernd Jilma. (2020) Bridging the Missing Link with Emicizumab: A Bispecific Antibody for Treatment of Hemophilia A. Thrombosis and Haemostasis 120:10, pages 1357-1370.
Crossref
Boris Gorovits, Kun Peng & Arno Kromminga. (2019) Current Considerations on Characterization of Immune Response to Multi-Domain Biotherapeutics. BioDrugs 34:1, pages 39-54.
Crossref
Sebastien Lacroix-Desmazes, Jan Voorberg, David Lillicrap, David W. Scott & Kathleen P. Pratt. (2020) Tolerating Factor VIII: Recent Progress. Frontiers in Immunology 10.
Crossref
Amanda D. Sankar, Angela C. Weyand & Steven W. Pipe. (2019) The evolution of recombinant factor replacement for hemophilia. Transfusion and Apheresis Science 58:5, pages 596-600.
Crossref
Angela C. Weyand & Steven W. Pipe. (2019) New therapies for hemophilia. Blood 133:5, pages 389-398.
Crossref
Prashant Sharma. 2019. Hematopathology. Hematopathology 389 400 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.